The subpopulations of Treg CD8+CTLA-4+ suppress the immune response against tumor, inhibiting the proliferation of effector T lymphocytes, where they can participate in the regulatory mechanism of IL-35 [38] and are also able to inhibit dependent allogeneic responses [39]. Here, CD8A is linked to neoplasm.